Navigation Links
OpenClinica to Present at International Conference on Health Informatics, January 14-17, Porto, Portugal
Date:1/8/2009

The International Conference on Health Informatics (HEALTHINF 2009) will feature OpenClinica in a special workshop titled "Open Source in European Health Care: The Time is Ripe"

Porto, Portugal (PRWEB) January 8, 2009 -- OpenClinica will be presented at a special workshop of the upcoming International Conference on Health Informatics (HEALTHINF 2009) January 14-17, 2009 in Porto, Portugal. The workshop, titled "Open Source in European Health Care: The Time is Ripe," brings together parties interested in how open source eHealth technologies tackle specific challenges within the healthcare sector.

Representing OpenClinica will be Benjamin Baumann, Director of Business Development at Akaza Research, the primary sponsor of OpenClinica. The presentation will demonstrate how OpenClinica enables electronic data capture (EDC) and clinical data management (CDM) for diverse types of clinical trials. In addition, the session will provide an overview of regulatory concerns associated with using open source software in regulatory environments, and specific points of integration between OpenClinica and other types of health IT systems, such as electronic medical records (EMR/EHR) systems.

For more information about the event, see: http://www.biostec.org/OSEHC.htm.

About OpenClinica®

OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates study protocol configuration, data collection via electronic case report forms (eCRFs), and enables productive clinical trials management. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulator guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. All versions of OpenClinica are available for free download from http://www.openclinica.org.

About Akaza Research®

Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the he world's most popular open source clinical research software. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for all types of clinical research. Akaza Research provides OpenClinica support, training, hosting and other value added services to its customers worldwide. See http://www.akazaresearch.com.

# # #

Read the full story at http://www.prweb.com/releases/2009/01/prweb1832004.htm


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. OpenClinica EDC Solution Deployed for Retina Implant Studies
2. Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials
3. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
4. Avicena Group to Present at Noble Financial Conference
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CEL-SCI to Present at the Noble Financial Conference
9. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Strategic Diagnostics Updates Roth Conference Presentation Time
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
OpenClinica to Present at International Conference on Health Informatics, January 14-17, Porto, Portugal
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... Tunnell Consulting, ... Based in Paris, he will focus on acquiring new accounts and work closely ... , “Fred brings to our European clients more than 15 years ...
(Date:2/9/2016)... ... February 09, 2016 , ... PharmApprove announced ... the National Organization for Rare Disorders (NORD). Dorman will lead PharmApprove efforts to ... heard throughout the drug regulatory review process. , “Adding Diane Dorman is just ...
(Date:2/9/2016)... and LONDON , February 9, 2016 ... bio tech replace paper and protect IP ... electronic laboratory notebook (ELN) will be rolled out in ... research and development (R&D) and protect valuable IP. Users will ... follow a specific researcher or experiment as part of the ...
(Date:2/9/2016)... LONDON , Feb. 9, 2016 /PRNewswire/ ... (PTP1B) Inhibitors-Pipeline Insights, 2016", report provides in ... their development activities around the Protein-Tyrosine Phosphatase ... the product profiles in various stages of ... Phase II, Phase III and Preregistration. Report ...
Breaking Biology Technology:
(Date:1/25/2016)...   Unisys Corporation (NYSE: UIS ) today announced ... International Airport, New York City , to help ... to enter the United States using passports ... pilot testing of the system at Dulles last year. The ... during January 2016. --> pilot testing of the ...
(Date:1/22/2016)... , Jan. 22, 2016 ... addition of the "Global Biometrics Market ... their offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ... "Global Biometrics Market in Retail Sector ... --> Research and Markets ( ...
(Date:1/20/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce the attainment of record-setting corporate ... of the company,s laser focus on (and growing international ... comprehensive, easy-to-use and highly affordable cloud-based technology platform. ... growth achievements in 2015 include: , Record ...
Breaking Biology News(10 mins):